ANDA Approval Speed-Up Leaves Sponsors With Less Margin For Error
Executive Summary
Get applications in right, or get a complete response letter, FDA says; firms will have fewer opportunities for mid-review application corrections as review goals reach 10 months.
You may also be interested in...
ANDA Sponsors Need To 'Slow Down' And Focus On Quality, US FDA Generics Director Says
ANDA Sponsors Need To 'Slow Down' And Focus On Quality, US FDA Generics Director Says
Sentinel May Expand To Generic Equivalence Studies
Tool being designed for rapid queries of US Sentinel data to consider generic drug switches, potentially spot equivalence problems.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: